Home » Topics » BioWorld Science

BioWorld Science
RSS

Homology Medicines nominates in vivo gene editing development candidate for PKU

Jan. 8, 2019

Incyte begins phase I study of INCB-086550 in advanced solid tumors

Jan. 8, 2019

SH-498 presented as a promising anti-BMI-1 compound for colorectal cancer

Jan. 8, 2019

Final safety results presented from phase I study of BT-11 in healthy volunteers

Jan. 8, 2019

BlackThorn Therapeutics offers pipeline update

Jan. 8, 2019

BCAR3 as novel biomarker of prognosis in patients with multiple myeloma

Jan. 8, 2019

Discontinuing tumor treatment can push cells into temporary retirement

Jan. 8, 2019

Gut-derived plasma cells suppress MS

Jan. 8, 2019

PTMs affect, as well as are affected by, protein folding

Jan. 8, 2019

CD16-IL-15-CLEC12A TriKE demonstrates preclinical activity in models of AML

Jan. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...